Keith Xavier, MD, URPS, highlights data from the TITAN 2 study looking at the impact of site of service on outcomes with the Medtronic implantable tibial neuromodulation system.
Keith Xavier, MD, URPS
Advertisement
Keith Xavier, MD, URPS, is a urologist at Urology Partners of North Texas.
Articles by Keith Xavier, MD, URPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves tebipenem pivoxil for complicated urinary tract infections
2
Behind the FDA approval of capivasertib for mHSPC, with Daniel J. George, MD
3
The ArteraAI Prostate Test: What It Is and How It Works
4
Louise Emmett, MD, PhD, highlights early data on 225Ac-PSMA-617 in mCRPC
5